(2R,2'R)-N,N'-((5S,15S)-8-carbamoyl-6,14-dioxo-2,18-dithia-7,13-diazanonadecane-5,15-diyl)bis(6-amino-2-(6,12-diallyl-9,15-bis(2-methoxyethyl)-4,7,10,13,16-pentaoxo-3,6,9,12,15,18-hexaazahenicos-20-enamido)hexanamide)

ID: ALA4590476

Chembl Id: CHEMBL4590476

PubChem CID: 155568182

Max Phase: Preclinical

Molecular Formula: C82H141N21O21S2

Molecular Weight: 1821.29

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CCNCC(=O)N(CCOC)CC(=O)N(CC=C)CC(=O)N(CCOC)CC(=O)N(CC=C)CC(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCCCCC(NC(=O)[C@H](CCSC)NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)CN(CC=C)C(=O)CN(CCOC)C(=O)CN(CC=C)C(=O)CN(CCOC)C(=O)CNCC=C)C(N)=O

Standard InChI:  InChI=1S/C82H141N21O21S2/c1-13-32-86-51-70(108)100(39-43-121-7)57-74(112)98(37-17-5)55-76(114)102(41-45-123-9)59-72(110)96(35-15-3)53-68(106)89-49-66(104)91-62(26-19-22-30-83)80(118)94-64(28-47-125-11)79(117)88-34-24-21-25-61(78(85)116)93-82(120)65(29-48-126-12)95-81(119)63(27-20-23-31-84)92-67(105)50-90-69(107)54-97(36-16-4)73(111)60-103(42-46-124-10)77(115)56-99(38-18-6)75(113)58-101(40-44-122-8)71(109)52-87-33-14-2/h13-18,61-65,86-87H,1-6,19-60,83-84H2,7-12H3,(H2,85,116)(H,88,117)(H,89,106)(H,90,107)(H,91,104)(H,92,105)(H,93,120)(H,94,118)(H,95,119)/t61?,62-,63-,64+,65+/m1/s1

Standard InChI Key:  PSGWFQVJYMQGCP-DWAMNDBISA-N

Alternative Forms

  1. Parent:

    ALA4590476

    ---

Associated Targets(Human)

HCC4017 (113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1821.29Molecular Weight (Monoisotopic): 1820.0052AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Singh J, Shukla SP, Desai TJ, Udugamasooriya DG..  (2016)  Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1.,  24  (18): [PMID:27485601] [10.1016/j.bmc.2016.07.045]

Source